Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/14/18 16:30 | 3/13/18 | RGRX | Health | Drug | Pharmaceutical Preparations | Sinaf S.A. | N4 | T | S.d | -2,665 | 0.2300 | 0 | -11,585 | -100 | 0 | D | |||||||||||||||
6/4/09 16:34 | 6/2/09 | RGN | Health | Drug | Pharmaceutical Preparations | Hindin Richard J | MD | D | S | -250 | 0.4000 | 0 | -625 | -39 | 968 | D | |||||||||||||||
5/30/06 17:23 | 5/26/06 | RGN | Health | Drug | Pharmaceutical Preparations | Finkelstein J J | MD | DO | P,CEO | S.d | -350 | 2.80 | 0 | -125 | -8 | 1,457 | B | ||||||||||||||
8/2/05 14:40 | 8/1/05 | RGN | Health | Drug | Pharmaceutical Preparations | Goldstein Allan L | MD | D | S.d | -352 | 3.20 | 0 | -110 | -5 | 1,958 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |